Gynofem Healthcare and Pharmaceutical Unlisted Share Price

The minimum lot is 160 share(s); at the indicative price of about ₹64, that is approximately ₹10,240. Indicative reference, not a quote.

As of 16 July 2026, the indicative unlisted share price of Gynofem Healthcare and Pharmaceutical is ₹64 per share. This is an over-the-counter reference price, not a stock-exchange quote.

The ISIN of Gynofem Healthcare and Pharmaceutical is INE0NLL01017. An ISIN is the unique 12-character code that identifies a company's shares in the depository system; this one is verified against NSDL (the National Numbering Agency). You need it to hold or transfer these unlisted shares in your NSDL or CDSL demat account.

Gynofem Healthcare and Pharmaceuticals Limited is an Indore-based pharmaceutical company incorporated in 2022 that develops and markets formulations focused on women's health, including gynaecology, fertility, maternal nutrition and post-delivery care. It distributes its products through healthcare professionals and a domestic field network covering urban and rural markets, and invests in research and development in gynaecology and obstetrics.

No. Gynofem Healthcare and Pharmaceuticals is currently an unlisted company and its shares do not trade on the NSE or BSE. Its equity changes hands in the private, unlisted market. Any listing or IPO would happen only if and when the company completes the required regulatory process; no listing has taken place as of now.

Unlisted shares are transacted privately rather than on an exchange, and availability and indicative pricing vary over time. You can contact the Unlisted Axis team for current information on availability, the transfer process and documentation. This is general information only and not investment advice; please assess suitability independently before transacting.

Unlisted and pre-IPO shares carry higher risk and lower liquidity than listed securities, meaning they can be difficult to sell quickly and at a predictable price. Audited financial disclosures may be limited, valuations can be uncertain, prices can move sharply, and there is no guarantee that the company will ever list. This content is informational and not a recommendation to buy, sell or hold.

They can. If the company declares a dividend, unlisted shareholders are eligible like any other shareholder. Many unlisted firms reinvest profits, so dividends are not guaranteed.

After listing, unlisted shares convert into regular listed shares in your demat account and can be traded on the exchange, usually once any applicable SEBI lock-in period ends.

Unlisted shares are less liquid than listed shares. You can sell when a buyer is available through an off-market transfer; there is no continuous exchange market, so exits can take longer.

Unlisted shares carry higher risk and lower liquidity than listed shares, with fewer disclosures and no live market price. This is general information, not investment advice — assess suitability before investing.

An unlisted share price is an indicative, over-the-counter reference set by demand and supply in private deals between buyers and sellers. There is no live exchange quote, so prices can vary across dealers and over time.

Yes. Unlisted shares are delivered in dematerialised form, so you need an active demat account (NSDL or CDSL). No special account type is required — a regular demat account works.

Unlisted shares are sold through an off-market transfer to a buyer via a registered intermediary, settling from your demat account with a contract note. Liquidity depends on buyer availability, so exits can take longer than listed shares.